<DOC>
	<DOCNO>NCT00028977</DOCNO>
	<brief_summary>RATIONALE : The Chinese herb Scutellaria barbata contains ingredient may slow growth cancer cell may effective treatment metastatic breast cancer . PURPOSE : Phase I/II trial study effectiveness Scutellaria barbata treat woman metastatic breast cancer .</brief_summary>
	<brief_title>Herbal Therapy Treating Women With Metastatic Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy Scutellaria barbata ( Chinese herbal extract ) term tumor response woman metastatic breast cancer . - Determine safety toxicity therapy patient . - Determine feasibility therapy patient . - Determine time progression , overall survival , resource utilization patient treat therapy . - Determine quality life patient treat therapy . - Determine bioavailability pharmacokinetics therapy patient . OUTLINE : Patients receive oral Scutellaria barbata ( Chinese herbal extract ) twice daily 12 month absence disease progression unacceptable toxicity . Quality life assess baseline every 6 month thereafter . PROJECTED ACCRUAL : A total 25 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm breast cancer ( may include original primary cancer diagnosis ) Measurable disease Metastatic involvement minimal symptom Solitary metastasis require histological confirmation No extensive liver involvement ( 50 % liver parenchyma ) No lymphangitic pulmonary involvement CNS involvement spinal cord compression allow stabilized therapy 3 month Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : ECOG 01 Life expectancy : More 6 month Hematopoietic : WBC least 2,500/mm^3 Platelet count least 75,000/mm^3 Hepatic : See Disease Characteristics Bilirubin great 1.7 mg/dL Renal : Creatinine great 2.0 mg/dL Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception No history multiple severe food medicine allergy PRIOR CONCURRENT THERAPY : Biologic therapy : At least 1 week since prior biologic therapy No concurrent anticancer biologic therapy Chemotherapy : At least 1 week since prior chemotherapy No concurrent anticancer chemotherapy Endocrine therapy : At least 1 week since prior hormonal therapy No concurrent anticancer hormonal therapy Radiotherapy : Not specify Surgery : Not specify Other : Recovered prior anticancer therapy At least 1 week since prior investigational agent At least 1 week since prior herbal medication No concurrent anticancer therapy No concurrent investigational agent Concurrent pamidronate allow Concurrent acupuncture nonherbal therapy allow Concurrent nutritional vitamin supplementation ( 5 time recommended daily allowance ) allow</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
</DOC>